C07B 59/002
Heterocyclic compounds
Official title: {Heterocyclic compounds}
C07B59/002 (Heterocyclic compounds) appears on 912 US grants and 1,842 published applications in this corpus.
Search patents in C07B- Granted patents
- 912
- Published applications
- 1,842
- Assignees
- 714
- Inventors
- 4,780
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 1 |
| 2002 | 3 | 5 |
| 2003 | 2 | 3 |
| 2004 | 5 | 5 |
| 2005 | 1 | 3 |
| 2006 | 4 | 6 |
| 2007 | 0 | 7 |
| 2008 | 1 | 9 |
| 2009 | 4 | 21 |
| 2010 | 6 | 25 |
| 2011 | 5 | 28 |
| 2012 | 16 | 30 |
| 2013 | 28 | 59 |
| 2014 | 24 | 53 |
| 2015 | 55 | 89 |
| 2016 | 52 | 100 |
| 2017 | 84 | 124 |
| 2018 | 98 | 111 |
| 2019 | 90 | 98 |
| 2020 | 71 | 83 |
| 2021 | 55 | 89 |
| 2022 | 40 | 121 |
| 2023 | 47 | 84 |
| 2024 | 53 | 134 |
| 2025 | 57 | 181 |
| 2026 | 55 | 373 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds, compositions, and methods29 Sep 2026US 12,747,232 B2Denali Therapeutics Inc.
- Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer22 Sep 2026US 12,741,964 B2Cornell University
- Selective transition metal catalyzed deuterium incorporation into alkyne and alkene functionalities15 Sep 2026US 12,735,369 B2Marquette University
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- KRas inhibitors1 Sep 2026US 12,723,053 B2Eli Lilly and Company
- Organic compounds8 Oct 2026US 2026/0306489 A1Intra-Cellular Therapies, Inc.
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Cdk2 inhibitors and methods of using same8 Oct 2026US 2026/0308145 A1Guangdong Touchstone Translational Research Institute Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Pyrazolotriazinecarbonitriles useful as kinase inhibitors8 Oct 2026US 2026/0308156 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Method of using deuterated calcium channel blockers334US 6,221,335 B1Isotechnika Inc. · 2001
- Enhancement of the efficacy of nifedipine by deuteration322US 5,846,514 AIsotechnika Inc. · 1998
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- Method of using deuterated calcium channel blockers283US 6,334,997 B12002
- Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors249US 7,598,257 B2Incyte Corporation · 2009